Modulation of the gut microbiome using a novel probiotic–prebiotic may have helped relieve symptoms related to post-acute COVID-19 syndrome, according to a late-breaking abstract presented at Digestive Disease Week 2023, in Chicago.
“This is the first randomized controlled trial showing that modulation of the gut microbiome with a novel microbiome formula alleviates gastrointestinal and neuropsychiatric symptoms of post-acute COVID-19 syndrome,” said lead